Method for preparing lisinopril intermediate

US10633329B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10633329-B2
Application numberUS-201716461589-A
CountryUS
Kind codeB2
Filing dateNov 17, 2017
Priority dateNov 17, 2016
Publication dateApr 28, 2020
Grant dateApr 28, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for preparing a lisinopril intermediate is provided. The method includes: treating (R)-hydroxy-4-phenylbutyrate with sulfonyl chloride in an organic solvent in the presence of a base to obtain a solution of sulfonate; reacting the obtained solution with a salt of trifluoroacetyl lysine; and obtaining a N2-[1-(S)-alkoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysine by separating after the reaction is completed. The method provided has a shorter synthesis route, is easy to operate, has a low cost, and is suitable for industrial production.

First claim

Opening claim text (preview).

The invention claimed is: 1. A preparation method of N 2 -[1-(S)-alkoxycarbonyl-3-phenylpropyl]-N 6 -trifluoroacetyl-L-lysine (II), wherein the method comprises the following steps: (a) treating (R)-2-hydroxy-4-phenylbutyrate (I) with a sulfonyl chloride (III) in an organic solvent in the presence of a base to obtain a solution of sulfonate of formula (I); (b) reacting the solution prepared above with a salt of trifluoroacetyl lysine, and obtaining the compound represented by formula (II) by a separation after the reaction is completed, in the above formulas: R 1 is selected from C 1 -C 5 alkyls; R 2 is selected from C 1 -C 3 alkyls or substituted alkyls, C 6 -C 7 aryls or substituted aryls. 2. The preparation method according to claim 1 , wherein, R 1 is selected from the group consisting of methyl, ethyl and isopropyl. 3. The preparation method according to claim 1 , wherein, the organic solvent described in step (a) is selected from the group consisting of C 2 -C 7 ethers, C 2 -C 4 halogenated alkanes, C 7 -C 10 aromatic compounds and a mixed solvent of any two thereof. 4. The preparation method according to claim 1 , wherein, the mass-to-volume ratio of (R)-2-hydroxy-4-phenylbutyrate (I) to the organic solvent in step (a) is 1 g:2-20 mL. 5. The preparation method according to claim 1 , wherein, the base is selected from the group consisting of carbonates or bicarbonates of alkali metals, C 5 -C 8 pyridine compounds, C 4 -C 9 secondary or tertiary amines. 6. The preparation method according to claim 1 , wherein, the molar ratio of the base to (R)-2-hydroxy-4-phenylbutyrate (I) is 1-10:1. 7. The preparation method according to claim 1 , wherein, the sulfonyl chloride (III) is selected from the group consisting of methylsulfonyl chloride, trifluoromethylsulfonyl chloride, p-nitrobenzenesulfonyl chloride and p-toluenesulfonyl chloride. 8. The preparation method according to claim 1 , wherein, the molar ratio of the sulfonyl chloride (III) to (R)-2-hydroxy-4-phenylbutyrate represented by formula (I) is 1-5:1. 9. The preparation method according to claim 1 , wherein, the temperature range within which the sulfonyl chloride is added is from −5° C. to 15° C.; the range of the reaction temperature of step (a) is 20-60° C. 10. The preparation method according to claim 1 , wherein, the salt of trifluoroacetyl lysine is selected from the group consisting of alkali metal salts of trifluoroacetyl lysine, C 4 -C 12 quaternary ammonium salts of trifluoroacetyl lysine. 11. The preparation method according to claim 1 , wherein, the molar ratio of the salt of trifluoroacetyl lysine to (R)-2-hydroxy-4-phenylbutyrate (I) is 1-6:1. 12. The preparation method according to claim 1 , wherein, the range of the reaction temperature of step (b) is 10-80° C. 13. The preparation method according to claim 1 , wherein, the method further comprises crystallizing the crude compound represented by formula (II) obtained by separation in a crystallization solvent, the crystallization solvent is selected from the group consisting of methanol, ethanol, ethyl acetate, isopropyl acetate, methyl tertiary butyl ether, n-hexane, n-heptane, cyclohexane or a mixed solvent of any two thereof; the mass-to-volume ratio of (R)-2-hydroxy-4-phenylbutyrate (I) to the crystallization solvent used is 1 g:2-20 mL; the range of crystallization temperature is from −5° C. to 60° C. 14. The preparation method according to claim 1 , wherein, the organic solvent described in step (a) is tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane, toluene, xylene or a mixed solvent of any two thereof. 15. The preparation method according to claim 1 , wherein, the mass-to-volume ratio of (R)-2-hydroxy-4-phenylbutyrate (I) to the organic solvent in step (a) is 1 g: 5-10 mL. 16. The preparation method according to claim 1 , wherein, the base is selected from sodium carbonate, potassium carbonate, sodium bicarbonate, pyridine, 2,6-lutidine, triethylamine, diisopropylamine. 17. The preparation method according to claim 1 , wherein, the molar ratio of the sulfonyl chloride (III) to (R)-2-hydroxy-4-phenylbutyrate represented by formula (I) is 1.1-3:1. 18. The preparation method according to claim 1 , wherein, the temperature range within which the sulfonyl chloride is added is from −5° C. to 10° C.; the range of the reaction temperature of step (a) is 20-40° C. 19. The preparation method according to claim 1 , wherein, the salt of trifluoroacetyl lysine is selected from a lithium salt of trifluoroacetyl lysine, a sodium salt of trifluoroacetyl lysine, a tetramethylammonium salt of trifluoroacetyl lysine. 20. The preparation method according to claim 1 , wherein, the range of the reaction temperature of step (b) is 20-60° C.

Assignees

Inventors

Classifications

  • C07C227/08Primary

    by reaction of ammonia or amines with acids containing functional groups · CPC title

  • by reaction of hydroxy compounds with sulfonic acids or derivatives thereof · CPC title

  • Optical isomers · CPC title

  • C07C229/36Primary

    with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10633329B2 cover?
A method for preparing a lisinopril intermediate is provided. The method includes: treating (R)-hydroxy-4-phenylbutyrate with sulfonyl chloride in an organic solvent in the presence of a base to obtain a solution of sulfonate; reacting the obtained solution with a salt of trifluoroacetyl lysine; and obtaining a N2-[1-(S)-alkoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysine by separating a…
Who is the assignee on this patent?
Zhejiang Huahai Pharm Co Ltd, Zhejiang Huahai Tiancheng Pharmaceuticals Co Ltd, Zhejiang Huahai Licheng Pharmaceuticals Co Ltd, and 1 more
What technology area does this patent fall under?
Primary CPC classification C07C227/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).